PAREXEL International Corp (PRXL)
$12.42
-0.39 (-3.04%)
| CAPS Rating |
|
|---|---|
| Open | $12.42 |
| Previous Close | $12.81 |
| Daily Range | $12.36 - $12.71 |
| 52-Week Range | $6.80 - $16.62 |
| Market Cap | $722.24M |
| P/E Ratio | 19.52 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 161,244 |
| Average Daily Volume | 486,000 |
PRXL
VS S&P 500 (SPY)
How do you think PRXL will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PRXL Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PRXL News and Commentary
- Pharma Researchers Need a Cure – The Motley Fool
- UPDATE 1-Parexel posts lower Q1 profit, sees Q2 below estimates – Reuters
- current watchlist – Blog at The Motley Fool
- Canaries in the Drug Coal Mine – The Motley Fool
- 5-Star Stocks Poised to Pop: Pharmaceutical Product – The Motley Fool
- Drug CROs: Good Medicine for Investors – The Motley Fool
- The 10 Biggest Nasdaq Losers of October – The Motley Fool
- Fearful Stocks for Greedy Investors – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- Recession Schmession, This Industry Is On Fire – The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- WuXi's Shortsighted Deal – The Motley Fool
- Anatomy of a Drug Development Trainwreck, Part II: The Northwick Tragedy – Blog at The Motley Fool
- Today's 5-Star Movers – The Motley Fool
- 5 All-Star Stocks on Fire – The Motley Fool
- Wednesday's Top 5 Growth Winners – The Motley Fool
- Clinical Trial Failures Don't Bother These Companies – The Motley Fool
- Stocks Everyone Says to Buy Now – The Motley Fool
- Opportunities in Outsourcing – The Motley Fool
RSS Headlines
Fool UK
